FDA approved a new drug to treat a type of cancer that affects the pancreas or gastrointestinal tract.
A pharmaceutical formulation of purified cannabidiol, a cannabinoid without euphoric side effects, is expected to launch in the second half of this year.
A patient advocacy group is criticizing the hefty price tag of a new treatment for blindness.
Patients with systemic lupus erythematosus often self-manage their corticosteroid medication without the consent of their healthcare providers, according to a recent multicountry survey.
FDA is taking its toughest stance yet on opioid-containing cough and cold medications for children.
FDA approved the first drug to treat certain patients with metastatic breast cancer who have a “BRCA” gene mutation.
Here are 3 of the top new drug approvals in late December and early January.
While hospitals continue to face IV saline shortages after two hurricanes significantly damaged infrastructure in Puerto Rico, the situation should improve early this year.
New blockbuster drugs to treat various conditions are expected to be among the top drugs to hit the marketplace in 2018. Here are 5 of the top new drugs in the pipeline for 2018, according to analysts.
FDA expanded the indication on cabozantinib (Cabometyx, Exelixis) to treat patients with advanced renal cell carcinoma (RCC).